Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT
Purple Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 62K | n/a | n/a | n/a | 196.00 | n/a | n/a | n/a | 120.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -196 | n/a | n/a | n/a | -120 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.41M | -1.02M | -2.13M | -3.46M | -4.47M | -6.27M | -5.75M | -5.13M | -5.12M | -6.6M | -5.08M | 3.59M | -7.33M | -4.45M | -3.04M | -3.62M | -6.53M |
Interest Income | 54K | n/a | 130K | 121K | 95K | n/a | 708K | 123K | 278K | 576K | 248K | 89K | 56K | 56K | 68K | 78K | 118K |
Pretax Income | -456K | -415K | -668K | -2.42M | -3.78M | -4.86M | -5.05M | -5.16M | -4.9M | -6.04M | -4.85M | -3.55M | -7.32M | -4.46M | -3.15M | -3.65M | -6.57M |
Net Income | -453K | -410K | -663K | -2.4M | -3.76M | -4.83M | -5.04M | -5.14M | -4.88M | -6.01M | -4.82M | -3.54M | -7.3M | -5.07M | -3.14M | -3.63M | -6.55M |
Selling & General & Admin | 646K | 310K | 785K | 865K | 1.04M | 829K | 1.16M | 1.43M | 1.62M | 1.53M | 1.62M | 1.51M | 1.38M | 1.44M | 1.42M | 1.53M | 1.67M |
Research & Development | 760K | 458K | 1.35M | 2.39M | 3.42M | 5.24M | 4.59M | 3.71M | 3.5M | 4.82M | 3.46M | 2.08M | 5.95M | 3.07M | 1.79M | 2.09M | 5.01M |
Other Expenses | n/a | 248K | n/a | 202K | n/a | n/a | n/a | n/a | n/a | 135K | n/a | n/a | n/a | 67K | n/a | n/a | n/a |
Operating Expenses | 1.41M | 1.02M | 2.13M | 3.46M | 4.47M | 6.27M | 5.75M | 5.13M | 5.12M | 6.6M | 5.08M | 3.59M | 7.33M | 4.58M | 3.2M | 3.62M | 6.67M |
Interest Expense | 35K | n/a | 511K | 24K | 17K | n/a | 16K | 148K | 59K | 18K | 16K | 51K | 41K | 69K | 21K | 102K | 20K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.66M |
Cost & Expenses | 1.41M | 1.02M | 2.13M | 3.46M | 4.47M | 6.27M | 5.75M | 5.13M | 5.12M | 6.6M | 5.08M | 3.59M | 7.33M | 31.42M | 3.2M | -3.62M | 6.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.11M | 37K | n/a | -6.34M | -7.18M | -2K |
Shares Outstanding (Basic) | 13.16K | 2.59M | 1.74M | 1.38M | 1.3M | 1.23M | 1.07M | 1.05M | 1.04M | 924.08K | 902.03K | 894.21K | 890.02K | 1.02M | 875.62K | 876.03K | 868.88K |
Shares Outstanding (Diluted) | 13.16K | 2.59M | 1.74M | 1.38M | 1.3M | 1.23M | 1.07M | 1.05M | 1.04M | 924.08K | 902.03K | 894.21K | 890.02K | 1.02M | 875.61K | 876.51K | 868.86K |
EPS (Basic) | -34 | -0.00 | -0.00 | -0.02 | -0.03 | -0.04 | -0.05 | -0.05 | -0.05 | -0.07 | -0.05 | -0.04 | -0.08 | -5 | -3.58 | -4.14 | -7.54 |
EPS (Diluted) | -34 | -0.00 | -0.00 | -0.02 | -0.03 | -0.04 | -0.05 | -0.05 | -0.05 | -0.07 | -0.05 | -0.04 | -0.08 | -5 | -3.58 | -4.14 | -7.54 |
EBITDA | -376K | -886K | -108K | -2.34M | -3.72M | -4.98M | -4.99M | -4.96M | -4.8M | -6.03M | -4.79M | -3.45M | -7.22M | -4.47M | -2.91M | -3.48M | -6.37M |
EBIT | -421K | -926K | -157K | -2.39M | -3.76M | -5.03M | -5.04M | -5.01M | -4.84M | -6.08M | -4.83M | -3.5M | -7.28M | -4.53M | -2.97M | -3.54M | -6.41M |
Depreciation & Amortization | 45K | 40K | 49K | 49K | 48K | 48K | 50K | 53K | 46K | 50K | 47K | 52K | 51K | 61K | 63K | 61K | 46K |